EUVIMEDEUVIMED entdecken
Crossref

Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma

Hao Xu, Hao Wang, Shi-Zhe Yu, Xiu-Ming Li, Dong-Lang Jiang, Yan-Fei Wu, Shu-Hua Ren, Lun-Xiu Qin, Yi-Hui Guan, Lu Lu, Wen-Wei Zhu, Xiao-Yang Wang und 1 weitere

European Radiology · 21.01.2025 · 35 (7) · 4121-4131

DOI: 10.1007/s00330-025-11352-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, online erschienen am 21.01.2025. Verfasst von Hao Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: the Major Program of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To assess the prognostic value of Fluorine 18-labeled fluorodeoxyglucose [18F]FDG, gallium 68-labeled fibroblast-activation protein inhibitor-04 [68Ga]Ga-FAPI-04, 11C-acetate in hepatocellular carcinoma (HCC) and evaluate the potential usefulness and advantages of different combinations for accurate diagnosis. MATERIALS AND METHODS: Thirty-six patients with suspected hepatic masses were prospectively enrolled from May 2021 to September 2022 and underwent [18F]FDG, [68Ga]Ga-FAPI-04, and 11C-acetate PET/CT scans before surgery. PET/CT results and histopathologic examinations were independently interpreted by two radiologists and pathologists, respectively. Kaplan-Meier overall survival curves were calculated and the sensitivity among [18F]FDG, 11C-acetate, [68Ga]Ga-FAPI-04, and different combinations were compared. RESULTS: Of the 36 included patients (mean age, 59 years ± 10 (standard deviation)), 29 were diagnosed with HCC, four with non-HCC malignant tumors, and three with benign tumors. Patients with HCC lesions negative for 11C-acetate or [68Ga]Ga-FAPI-04 exhibited poorer overall survival. Out of 36 patients, 44 HCC lesions were detected. The dual-tracer [68Ga]Ga-FAPI-04/11C-acetate exhibited the highest sensitivity (39 of 44 lesions (88.6%)) among all schemes. HCC lesions with higher histological grade and microvascular invasion (MVI) showed higher maximum standardized uptake value (SUVmax) and tumor-to-background ratio (TBR) of [18F]FDG, but no evidence of significant differences was found in [68Ga]Ga-FAPI-04 and 11C-acetate PET/CT. Higher expression of fibroblast activation protein (FAP) showed higher uptake of [68Ga]Ga-FAPI-04 and [18F]FDG. CONCLUSION: [68Ga]Ga-FAPI-04 and 11C-acetate PET/CT exhibited good predictive value for HCC patients, with their combination showing the highest sensitivity for HCC detection, suggesting potential for improved diagnostic protocols. KEY POINTS: Question What are the prognostic and diagnostic values of PET/CT tracers, including [18F]FDG, [68Ga]FAPI-04, and 11C-acetate? Findings Hepatocellular carcinoma, with differing findings across [18F]FDG, [68Ga]GaFAPI-04, and 11C-acetate PET/CT, showed varied prognoses; [68Ga]GaFAPI-04 and 11C-acetate combined offered the highest detection sensitivity. Clinical relevance Evaluating the prognostic value and diagnostic efficacy of different tracer combinations in patients with hepatocellular carcinoma helps to guide the optimal selection of tracers in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPositron Emission Tomography Computed TomographyHumansMiddle AgedMaleFemaleAcetatesPrognosisFluorodeoxyglucose F18RadiopharmaceuticalsAgedProspective StudiesGallium RadioisotopesSensitivity and SpecificityCarbon RadioisotopesAdultGallium IsotopesQuinolines

Stichwörter der Autor:innen

Carbon-11 acetateCarcinoma (hepatocellular)Fluorodeoxyglucose F18Positron emission tomography computed tomography[68Ga]Ga-FAPI

Substanzen

AcetatesFluorodeoxyglucose F18RadiopharmaceuticalsGallium Radioisotopes68Ga-FAPICarbon RadioisotopesGallium IsotopesQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
  • Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China. westoolife@163.com.
  • Department of Radiology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. 524438688@qq.com.
  • Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. fangxie@fudan.edu.cn.

Förderung

  • the Major Program of National Natural Science Foundation of China

Zitieren

APA

Xu, H., Wang, H., Yu, S. Z., Li, X. M., Jiang, D. L., Wu, Y. F., Ren, S. H., Qin, L. X., Guan, Y. H., Lu, L., Zhu, W. W., Wang, X. Y., & Xie, F. (2025). Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma. European Radiology, 35(7), 4121-4131. https://doi.org/10.1007/s00330-025-11352-3

Vancouver

Xu H, Wang H, Yu SZ, Li XM, Jiang DL, Wu YF, et al. Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma. European Radiology. 2025;35(7):4121-4131. doi:10.1007/s00330-025-11352-3

BibTeX
@article{Xu2025,
  author = {Xu, Hao and Wang, Hao and Yu, Shi-Zhe and Li, Xiu-Ming and Jiang, Dong-Lang and Wu, Yan-Fei and Ren, Shu-Hua and Qin, Lun-Xiu and Guan, Yi-Hui and Lu, Lu and Zhu, Wen-Wei and Wang, Xiao-Yang and Xie, Fang},
  title = {Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma},
  journal = {European Radiology},
  year = {2025},
  volume = {35},
  number = {7},
  pages = {4121--4131},
  doi = {10.1007/s00330-025-11352-3}
}
Kostenlos starten →